Changes in the proportions of CD4+ subtypes in SLE patients would generate disease associations at any loci that had cell type-specific methylation patterns, and as we have observed, these loci would likely have intermediate mean methylation levels due to the mixture of these cell types in the CD4+ population. The gene discussed is CD4; the disease is systemic lupus erythematosus.